SpeedWeed

SEPTEMBER 4, 2021

“DEA is proposing significant increases to the APQs of the schedule I substances psilocybin, psilocin, marihuana, and marihuana extract, which are directly related to increased interest by DEA registrants in the use of hallucinogenic controlled substances for research and clinical trial purposes,” the DEA writes. .

DEA 52

DEA Research and Development Clinical Trials Extraction 52

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. The respondents ranged in age from 19 to 81, and 50% identified as White, 20% as Latino, 12% as Asian, and 10% as Black.

Education 101

Education Clinical Trials Medicine Policy 101

Cannabis Law Report

SEPTEMBER 14, 2021

13, 2021 /PRNewswire-PRWeb/ — A host of scientific research and clinical trials around the world are affirming the remarkable effectiveness of psilocybin, the principal psychoactive component of “magic mushrooms,” in the treatment of a variety of medical conditions, including depression, anxiety, addiction, and PTSD.

Clinical Trials 52

Clinical Trials Events Medicine Therapy 52

Cannabis Law Report

JULY 9, 2021

The Horizons ETFs product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs has over $19 billion of assets under management and 95 ETFs listed on major Canadian stock exchanges.

Data 105

Data Clinical Trials Decriminalization Hemp 105

The Cannigma

AUGUST 26, 2021

Medical: Legal Recreational: Illegal (though at least one territory has adopted decriminalization). Qualifying conditions for medical marijuana. These products can only be accessed through the Special Access Scheme by an authorized healthcare practitioner, or as part of a clinical trial, according to the Office of Drug Control.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Otherside Farms

SEPTEMBER 28, 2019

FDA requires large-scale clinical trials to determine the benefits and risks of the plant but no such trials have come about. CBD oil (CBD extract + carrier oil) has been used to treat various health conditions such as stress, anxiety, nausea, cancer symptoms, and gastrointestinal problems, among others.

Dispensary 58

Dispensary Clinical Trials CBD THC 58

NewsMunchies

DECEMBER 13, 2021

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. In 2019, Denver became the first city in the U.S.

Clinical Trials 95

Clinical Trials Therapy Decriminalization Patients 95

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. Just last year, the state of Oregon passed legislation decriminalizing the use of all drugs in small amounts, including psilocybin.

Therapy 55

Therapy DEA Patients Clinical Trials 55

Canna Law Blog

NOVEMBER 6, 2021

Instead, qualifying evidence may come from adequate and well-controlled clinical trials. Phase I trials should be sufficient, and many have been completed using psilocybin. Some critics disparage such results and argue that existing trials are not large enough. Other evidence of currently accepted use is available.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

SpeedWeed

JULY 7, 2021

Although most subjects did not expect mescaline to help these conditions, the majority of them found that their symptoms actually improved after the trip. Researchers found that subjects who experienced ego dissolution or mystical-type psychological insight were more likely to report a significant improvement in their psychiatric conditions.

Clinical Trials 52

Clinical Trials Treatment Decriminalization Conditions 52

Cannabis Law Report

SEPTEMBER 10, 2019

Forbes reported on Hopkins researchers’ recommendation that, if psilocybin should clear Phase III clinical trials, the FDA should reclassify it from a Schedule I to a Schedule IV drug. Dr. Johnson speaks with Denver NBC News, offering his thoughts on the Denver initiative to decriminalize psilocybin.

Research and Development 45

Research and Development Microdosing Clinical Trials Decriminalization 45

Canna Law Blog

MARCH 4, 2020

Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). .”

Therapy 89

Therapy Legalization Chronic Pain DEA 89

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Global Legal Cannabis Industry: Number of Clinical Trials, By Region. Market Segmentation. Uruguay.

Recreational 95

Recreational Hemp THC Legalization 95

Canna Law Blog

MARCH 4, 2020

Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). .”

Legalization 52

Legalization Therapy Chronic Pain DEA 52

Cannabis Law Report

JULY 12, 2019

The opening of London’s first such clinic follows the opening of Britain’s first medical cannabis clinic in Greater Manchester earlier in the year. Access is clearly in demand from Londoners as there is already a waiting list of 150 patients at the London clinic ahead of its opening.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

The Cannigma

MARCH 12, 2021

However, many customers, new medical cannabis customers are going into the dispensary with a note from their doctor saying you qualify under one of the state conditions that enable you to use cannabis. I think when customers go to a dispensary, they’re assuming it’s going to be the same type of experience. How do you address that?

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

MAY 19, 2019

But in recent years, some nations have adopted a different strategy, of decriminalizing marijuana usage as a way of combating it. In countries as varied as the Netherlands, Germany, Mexico, Peru, and Canada, the emphasis has shifted towards the decriminalization of marijuana. It can improve lung health.

Legalization 45

Legalization Seed-To-Sale Marijuana Decriminalization 45

Cannabis Law Report

AUGUST 30, 2019

Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis. This scandal reflects the ongoing debate in Kenya over the possible passage of legislation to decriminalize cannabis use. Medical/Health.

Banking 45

Banking Research and Development Legislation Programs 45

The Cannigma

MAY 7, 2021

I think we’re needing to kind of understand how we classify medical cannabis in Europe in order to improve the volume of access for patients across Europe because at the minute, it’s still very restrictive in terms of who can prescribe and what they can prescribe and for what conditions of course, what they can prescribe for.

Supply Chain 120

Supply Chain Patients Access Hemp 120

SpeedWeed

JULY 31, 2021

Casey Weinstein and Terrence Upchurch, both representing Northeast Ohio districts, first introduced their 180-page bill two weeks ago, which includes four major components: decriminalization, a cannabis excise tax, commerce and licensing, and medical cannabis. The time is now, and I look forward to getting this done in a bipartisan fashion.”.

Legalization 52

Legalization Clinical Trials Decriminalization Research and Development 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Dr Rosalind Watts is a clinical psychologist, and the clinical lead of the Psilocybin for Depression trial at Imperial College London.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. Several bills have been introduced in Congress in 2019 that call for legalizing or decriminalizing the substance.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

JUNE 30, 2019

Lou Correa (D-CA) that would require the VA to conduct clinical trials on the therapeutic potential of cannabis in the treatment of such service-related conditions as post-traumatic stress disorder and chronic pain. The panel also took up a bill sponsored by Rep.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

DECEMBER 30, 2019

State lawmakers passed Assembly Bill 420 , which authorizes the University of California’s Center for Medicinal Cannabis Research to cultivate cannabis for clinical trials. State lawmakers passed HB 1383 , which decriminalizes activities involving the possession of up to three grams of marijuana. California.

Legislation 59

Legislation Patients Access Banking 59